Allison is Associate Editorial Director for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®. She joined AJMC® in 2017. She produces and oversees written, video, and podcast content across several disease states and issues surrounding value-based care and health policy.
She has an MPA from New York University. You can connect with Allison on LinkedIn.
COVID-19 and Cancer: Practices Seek to Protect Patients, Providers From Growing Pandemic
Some patients with cancer are more vulnerable than others, said Jeffrey Patton, MD, acting chief executive officer and president of physician services of OneOncology, as well as chief executive office of Tennessee Oncology, which is down to its last 14-day supply of personal protective equipment.
COVID-19 Exposes Cracks in Paid Sick Leave Policies
The president signed into law Wednesday the temporary Family First Coronavirus Response Act, which provides short-term paid sick leave benefits and longer-term paid family leave for some workers affected by the virus. However, it is not universal and provides for various exclusions.
CMS Unveils Temporary Change Allowing Wider Use of Telehealth During COVID-19 Pandemic
The temporary relaxation and expansion of CMS' telehealth rules, which allows the use of methods like FaceTime and Skype, is aimed at protecting both older patients and their providers from COVID-19, which has led to curfews, shuttered schools, deserted Main Streets, and ravaged financial markets.
What Protects Children From Suicidal Ideation? Liking School, Having Parental Supervision
Risk factors for suicidal ideation and behaviors in children aged 9 and 10, however, include psychological issues, conflict within the family, and increased use of computers on weekends, especially for boys.
Wash. State Sees First US Coronavirus Death and First Healthcare Worker Infected
A man in his 50s in Washington state with underlying health conditions became the first fatality from the coronavirus in the United States, and a healthcare worker and a resident from a nursing home in the state are hospitalized, the CDC said Saturday. It is the first reported case in a healthcare worker, the CDC said.
Biomarker Testing Can Direct Care, but Only If Clinicians Perform the Right Tests
Opportunities for precision medicine can be lost if clinicians do not perform biomarker testing, and payers may be part of the reason, according to Stuart Goldberg, MD, a hematologist/oncologist and chief of the Division of Outcomes and Value Research at the John Theurer Cancer Center at Hackensack University Medical Center in New Jersey.
Latest HCCI Report Shows Continued Increases for Those With Employer-Sponsored Health Insurance
Workers with health insurance through their jobs saw out-of-pocket costs rise 14.5%, or $114, between 2014 and 2018, and also increased the use of psychiatry services and substance use facilities.
Do Americans Have the Political Will to Tackle Healthcare Costs? A Q&A With Gail Wilensky, PhD
To mark the 25th anniversary of the journal, each issue in 2020 will include an interview with a healthcare thought leader. For the February issue, we turned to Gail Wilensky, PhD, an economist and senior fellow at Project HOPE.
In 1 Illinois District, Residents' Main Concern: Healthcare, Drug Costs, Legislator Says
Atul Grover, MD, PhD, the executive vice president for the Association of American Medical Colleges, sat down with Representative Lauren Underwood, D-Illinois, for a conversation about her healthcare-related efforts during her first year in Congress representing people from a suburban rural district 2 hours from Chicago.
CMS Agrees to Cover NGS for Medicare Patients With Breast, Ovarian, Other Cancers
CMS said it is expanding coverage of next generation sequencing (NGS) for use as a diagnostic for patients with germline breast and ovarian cancer, paving the way for Medicare beneficiaries to receive more personalized medicine. However, an advocate said the wording of CMS' decision could actually limit testing access for some women with breast or ovarian cancer.
What Accounts for the High Cost of Care? It’s the People: A Q&A With Eric Topol, MD
To mark the 25th anniversary of the journal, each issue in 2020 will include an interview with a healthcare thought leader. Because January is our annual health information technology issue, we turned to Eric Topol, MD, of Scripps Research.
Link Between Opioid Mortality, Auto Plant Closures Adds New Insight to Falling Life Expectancy
This week, researchers pinpointed the effects of shuttered automobile factories, releasing results in JAMA Internal Medicine that show plant closures from 1999 to 2016 were associated with increases in deaths from opioid overdoses.
Top 5 Most-Read Stories From 2019 Conference Coverage
Two new classes of drugs that offer significant clinical benefits for patients with diabetes and heart failure dominated medical conferences in 2019. Meanwhile, ovarian cancer guidelines were updated to add new therapies and the intersection of consumer health technology and cardiology also took over headlines. Read on for more.
Passing Rebates to Medicare Part D Beneficiaries Could Save Them $29 Billion, Report Says
A new analysis says allowing beneficiaries in Medicare Part D to benefit from drug manufacturer rebates shows that they could save $29 billion. But if another proposal is chosen, they would save less, and taxpayer costs would rise.
US Unveils Proposed Rules to Allow Some Canadian Drug Imports
Through a Notice of Proposed Rulemaking and a draft guidance for industry, the FDA will seek request for comment on 2 pathways. One would allow states to submit proposals to the FDA to allow the importation of small molecule brand-name medicines sold at retail pharmacies. The other is a draft guidance for industry, which would let manufacturers import the same versions of FDA-approved drugs they now sell in foreign countries.
Radiation Oncologist Discusses Concerns With Incoming CMS Payment Model
As CMS prepares to move forward with new models of value-based cancer care, a radiation oncologist, speaking at the Institute for Value-Based Medicine®, discussed her findings regarding whether accountable care models had an effect on cancer care spending.
Verma Faces Call to Resign From Lawmaker
Seema Verma, the CMS administrator and one of the last original high-level appointments by President Donald Trump still with the administration, faces her first call for resignation amid reports she sought taxpayer reimbursement for stolen uninsured jewelry during a work trip.